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Owing to environmental health concerns, a number of per- and polyfluoroalkyl substances (PFAS) have
been phased-out, and increasingly replaced by various chemical analogs. Most prominent among these
replacements are numerous perfluoroether carboxylic acids (PFECA). Toxicity, and environmental health
concerns associated with these next-generation PFAS, however, remains largely unstudied. The zebrafish
embryo was employed, in the present study, as a toxicological model system to investigate toxicity of a
representative sample of PFECA, alongside perfluorooctanoic acid (PFOA) as one of the most widely used,
and best studied, of the “legacy” PFAS. In addition, high-resolution magic angle spin (HRMAS) NMR was
utilized for metabolic profiling of intact zebrafish embryos in order to characterize metabolic pathways
associated with toxicity of PFAS. Acute embryotoxicity (i.e., lethality), along with impaired development,
and variable effects on locomotory behavior, were observed for all PFAS in the zebrafish model. Median
lethal concentration (LC50) was significantly correlated with alkyl chain-length, and toxic concentrations
were quantitatively similar to those reported previously for PFAS. Metabolic profiling of zebrafish em-
bryos exposed to selected PFAS, specifically including PFOA and two representative PFECA (i.e., GenX and
PFO3TDA), enabled elaboration of an integrated model of the metabolic pathways associated with
toxicity of these representative PFAS. Alterations of metabolic profiles suggested targeting of hepatocytes
(i.e., hepatotoxicity), as well as apparent modulation of neural metabolites, and moreover, were
consistent with a previously proposed role of mitochondrial disruption and peroxisome proliferator-
activated receptor (PPAR) activation as reflected by dysfunctions of carbohydrate, lipid and amino acid
metabolism, and consistent with a previously proposed contribution of PFAS to metabolic syndrome.
Taken together, it was generally concluded that toxicity of PFECA is quantitatively and qualitatively
similar to PFOA, and these analogs, likewise, represent potential concerns as environmental toxicants.
© 2020 Elsevier Ltd. All rights reserved.1. Introduction
Per- and polyfluoroalkyl substances (PFAS) are environmental
pollutants of emerging concern. Chemically speaking, the PFAS are
a class of highly fluorinated organic compounds in which all, or
most, hydrogen atoms of “long” (6 carbon) or “short” aliphatice by Sarah Harmon.
ng, Florida International Uni-
, USA.chains are substituted by fluorine, and to which terminal polar
functionalities (e.g., carboxylic acid, sulfonate) are typically added
(Fig. S1) in order to impart highly effective surfactant properties
(Prevedouros et al., 2006; Wang et al., 2017). Owing to these
properties, the PFAS have been extensively used since the late
1940s in a range of industrial and consumer applications including
textiles, household products (e.g., Teflon), cosmetics, firefighting
foams, medical devices, oil production, pesticide formulations, and
in water-repellants (KEMI, 2015; Prevedouros et al., 2006; Wang
et al., 2013).
Due to chemical recalcitrance bestowed by CeF bonds, PFAS are
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(Prevedouros et al., 2006; Wang et al., 2017), and have been widely
detected in the environment, wildlife and humans (Giesy and
Kannan, 2001; Prevedouros et al., 2006; KEMI, 2015; Wang et al.,
2017). Concentrations of PFAS in drinking water, for example,
typically range from 200 ng/L to a several parts-per-billion (ppb,
i.e., mg L1) (Sunderland et al., 2019). Levels of PFAS in fish and
seafood has, in turn, been generally reported in the range of a few to
hundreds ppb (i.e., ng g1), and has suggested, in fact, to be the
primary non-occupational route of human exposure to PFAS
(Domingo and Nadal, 2017; Fair et al., 2019). Moreover, studies by
the Center Disease Control (CDC) reported detection of PFAS in as
much as 98% of the U.S. population (Sunderland et al., 2019) with
typical serum concentrations of a few ppb, but up to parts-per-
million (ppm, i.e., mg L1) among occupationally exposed in-
dividuals (Worley et al., 2017; Anderson et al., 2019). Notably, a
recent study (Mamsen et al., 2019) found that PFAS can be trans-
ferred maternally via placenta to embryo and fetal tissues, reaching
ppb levels.
At the same time, PFAS have been demonstrated to have a range
of adverse effects relevant to human health including reproductive
toxicity, carcinogenicity, hormonal dysfunction, hepato/nephro-
toxicity, developmental toxicity, neurotoxicity, immunotoxicity,
and pulmonary effects (Lau et al., 2007; Prevedouros et al., 2006;
Shrestha et al., 2017; Steenland et al., 2009). One of the notable
links to human health e identified through both molecular and
epidemiological studies e has been a possible association with
metabolic syndrome including obesity and dyslipidemia, impair-
ment of glucose tolerance and regulation, and increased blood
pressure all of which are linked, in turn, to increased risks of heart
disease, stroke and diabetes, although findings in this regard have
been collectively inconclusive (Matilla-Santander et al., 2017;
Christensen et al., 2019; Sunderland et al., 2019). Based on available
data regarding adverse health effects, the U.S. Environmental Pro-
tection Agency (EPA) has previously proposed a lifetime health
advisory level of 70 ng/L in drinking water, though this has recently
been lowered (Sunderland et al., 2019).
Given their persistent and widespread distribution in the
environment, and potential for bioaccumulation and toxicity (and
consequent adverse health effects), the production and use of
several of the most common PFAS including, in particular, long
chain (6 C) representatives of perfluorocarboxylic acids, such as
perfluorooctanoic acid (PFOA; Fig. S1), and perfluoroalkyl sulfonic
acids, such as perfluorooctane sulfonate (PFOS), have been phased-
out in the United States and Europe (Perez et al., 2013; Substances
and Registry, 2015; Wang et al., 2017). These so-called “legacy”
PFAS, however, been largely replaced by a diversity of “next-gen-
eration” compounds. Among these are numerous per-
fluoroethercarboxylic acids (PFECA; Fig. S1) in which one or more
carbon (i.e., -CF2-) is replaced by an oxygen e as an ether group -
while still enabling similar chemical properties (Health and
Services, 2018; Substances and Registry, 2015; Wang et al., 2015).
Like legacy PFAS, however, this means PFECA are also highly stable,
and recent studies suggest that they are equally persistent, andmay
similarly bioaccumulate, in the environment (Sun et al., 2016;
Wang et al., 2015, 2013) This class of PFAS are, thus, emerging as a
potential concern as environmental toxicants (Prevedouros et al.,
2006; Wang et al., 2017). To date, however, there remains very
limited information on the PFECA with respect to toxicity, and
possible environmental health concerns (Wang et al., 2017, 2013).
Among the PFECA, in fact, only two of the most commonly used e
under the trade names, GenX (Fig. S1) and ADONA (4,8-dioxa-3H-
perfluorononanoate) - have been studied with respect to toxicity,and specifically in mammalian (i.e., mice and rat) systems (DeWitt,
2015; Wang et al., 2015).
Zebrafish (Danio rerio) and, in particular, early life stages (i.e.,
embryos and larvae) of the species, have become well established
as a vertebrate toxicological model (Berry et al., 2016, 2007; Jaja-
Chimedza et al., 2017; Roy et al., 2017; Weiss-Errico et al., 2017;
Zuberi et al., 2019). In addition to numerous practical advantages of
this system including ease of husbandry and breeding, high
fecundity, a small and nearly transparent embryo, and rapid (i.e.,
~3e5 day) embryogenesis, the zebrafish embryo - as a toxicological
model - is both potentially translational to human health, and
moreover, represents access to a wide range of relevant and
quantifiable toxiciological endpoints. As such, this model system
has been employed to investigate a myriad of environmental tox-
icants (Berry et al., 2007; Ulhaq et al., 2013; Weiss-Errico et al.,
2017; Zuberi et al., 2019). Indeed, zebrafish embryos and larvae -
and even adult stages e have been previously used to investigate
toxicity and toxicokinetics of PFAS including, in particular, PFOA,
PFOS and related compounds (Ulhaq et al., 2013; Vogs et al., 2019;
Weiss-Errico et al., 2017; Wen et al., 2019; Zheng et al., 2012). In the
present study, we utilized the zebrafish embryomodel to evaluate a
representative sample of PFECA with respect to their toxicity
including acute toxicity (i.e., lethality) and developmental impair-
ment, as well as behavioral endpoints. Although the zebrafish
embryo has been used previously to investigate several legacy PFAS
(e.g., PFOA, PFOS), the current study is among the first to investigate
the toxicity of the PFECA, in general, and in this model system
specifically.
Given the considerable promise of the zebrafish embryo model,
it is perhaps not surprising that a number of biotechnological ad-
vances have evolved alongside the toxicological model. Among
these is a wide range of “omics” approaches. Very recently, this has
included adaptations of nuclear magnetic resonance (NMR)-based
metabolomics techniques for metabolite profiling and imaging in
the zebrafish model (Chatzopoulou et al., 2015; Kabli et al., 2009;
van Amerongen et al., 2014). In particular, approaches based on
high-resolution magic angle spin (HRMAS) NMR have shown
remarkable potential for metabolomics of intact zebrafish (Berry
et al., 2016; Chatzopoulou et al., 2015; Kabli et al., 2009; Roy
et al., 2017; van Amerongen et al., 2014; Zuberi et al., 2019).
Briefly stated, HRMAS NMR utilizes spinning of a sample at the so-
called “magic angle” (of 54.74 relative to the magnetic field) to
minimize major interactions (specifically dipolar and quadrupolar
interactions, and chemical shift anisotropy) that, otherwise, cause
broadening of signal (i.e., “chemical shift”) peaks, and thus, enables
resolution of the chemical shifts of multiple compounds (e.g., me-
tabolites) even within complex biological samples including intact
zebrafish embryos. This technique has been previously applied to
understanding of metabolic contributions to disease state
(Chatzopoulou et al., 2015; van Amerongen et al., 2014), and more
recently, metabolic alterations associated with environmental
toxicants (Berry et al., 2016; Roy et al., 2017; Zuberi et al., 2019). In
the latter case, this approach was specifically applied to several
naturally occurring biotoxins (e.g., cyanobacterial toxins, myco-
toxins), and enabled facile characterization of integrated pathways
of toxicity, and identification of potential metabolic biomarkers of
toxin-specific effects (Berry et al., 2016; Roy et al., 2017; Zuberi
et al., 2019) In the present study, this state-of-the-art technique
was applied to a comparative toxicological investigation of PFECA
and PFOA as a means of characterizing pathways and targets of
PFAS toward an integrated systems-level model of toxicity in rela-
tion to possible health concerns.
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2.1. Chemicals
Perfluoroethercarboxylic acids (PFECA) including perfluoro (4-
methoxy butanoic) acid (PFMOBA), perfluoro-3,6,9-
trioxatridecanoic acid (PFO3TDA), perfluoro-3,6,9-trioxadecanoic
acid (PFO3DA), perfluoro (2-methyl-3-oxahexanoic) acid (trade-
marked commercially under the name “GenX”), perfluoro-3,6-
dioxaheptanoic acid (PFO2HpA), 4-(heptafluoroisopropoxy)hexa-
fluorobutanoic acid (PFDMMOBA) and Perfluoro-3,6-dioxadecanoic
acid (PFO2DA) were purchased from SynQuest Laboratories (Dallas,
TX U.S.A.). Perfluorooctanoic acid (PFOA), and all other chemicals
(i.e., deuterated phosphate buffer and reference standard for NMR),
were purchased from Sigma-Aldrich (St. Louis, MO, U.S.A.). Stock
solutions of PFECAs and PFOAwere prepared with deionized water
in polypropropylene tubes (to prevent adsorption to glass; Shafique
et al., 2017), and were sonicated until complete dissolution of the
compounds was achieved. All chemicals were utilized without
further purification.2.2. Zebrafish embryo toxicity assays
Zebrafish embryo toxicity of PFAS was assessed as previously
described (Berry et al., 2007; Jaja-Chimedza et al., 2017; Weiss-
Errico et al., 2017). Evaluation of toxicity was primarily conducted
in laboratories at Florida International University under protocols
approved by the FIU Animal Care and Use Committee (IACUC).
Additional details of rearing and breeding of zebrafish, and toxicity
assays, are given in the Supplementary Materials. For comparison
to a representative legacy PFAS, the toxicity of PFECA (and subse-
quent metabolic profiling experiments) was assessed alongside
PFOA for which toxicity in the zebrafish embryo model has been
previously evaluated (Hagenaars et al., 2011; Weiss-Errico et al.,
2017). Preliminary studies enabled establishment of effective con-
centration ranges for PFAS, and accordingly, embryos (PSA line
at  4 h post-fertilization [hpf]) were exposed to a concentration
series of 25, 50, 75, 100, 150, 200 ppm for PFMOBA, Gen X,
PFO2HPA, PFO3DA and PFOA; 100, 150, 200, 250 and 300 ppm for
PFDMMOBA; 5, 10, 50, 75 and 100 ppm for PFO2DA; and 1, 5, 10, 20,
30 and 40 ppm for PFO3TDA.
Embryo toxicity was observed, and recorded, at four develop-
mentally relevant timepoints, i. e., 1, 2, 5 and 7 days post-
fertilization (dpf), over 7-d continual exposure. Relevant toxico-
logical endpoints included lethality/mortality, developmental in-
hibition and neurobehavioral endpoints. With respect to mortality,
median lethal concentration (LC50) was calculated for each test
compound at each timepoint, based on percent mortality (N ¼ 3
replicates of 5 embryos per well) fitted to sigmoidal concentration-
response curves, specifically using Origin 2018b software (Origin
Lab, Northampton, Massachusetts, USA) with LC50 values calculated
by Probit Analysis in SPSS (version 23.0; IBM Corporation Armonk,
NY, USA, 2015). Alongside mortality, morphological developmental
deformities were recorded by light photomicrography using
Olympus DP2-BSW imaging software (Olympus, Center Valley, PA,
USA, 2009). Inhibition of development and behavioral dysfunction
were assessed, respectively, based on interocular distance (IOD)
and vestibular righting reflex (i.e., percent listing in 30 s interval,
n ¼ 6) for pooled surviving embryos (at 7 dpf), compared to un-
treated (E3 medium only) controls, as previously described (Weiss-
Errico et al., 2017). One-way ANOVA was used to calculate the
statistical significance of differences between LC50 values, calcu-
lated at each timepoint, and IOD and percent listing (at 7 dpf)
relative to untreated (E3 only) controls, for all treatments.2.3. Exposures for HRMAS-NMR metabolic profiling
Toward comparative characterization of targets and pathways of
toxicity, metabolic profiling of zebrafish exposed to three repre-
sentative PFAS - specifically PFOA, GenX and PFO3TDA e was per-
formed by HRMAS NMR, as previously described (Berry et al., 2016;
Roy et al., 2017; Zuberi et al., 2019). All exposures and subsequent
NMR analyses were conducted at the University of Leipzig with
embryos (OBI/WIK line) provided by the Helmholtz Center for
Environmental Research. Prior to NMR metabolomics studies,
additional assessments of toxicity were subsequently conducted in
laboratories to confirm toxicity in this line, in general, and to
determine relevant exposure parameters including sublethal con-
centrations and optimal developmental stage, for PFAS (i.e., PFOA,
GenX and PFO3TDA) selected for metabolomic studies. Details of
rearing and breeding of zebrafish, and these additional toxicity
assays, are given in the Supplementary Materials. Exposures for
NMR analyses were accordingly performed using 72 hpf embryos
exposed (in 25 mL of ISO medium (Kn€obel et al., 2012) in 75 cm2
tissue culture flasks) to final concentrations of PFOA, GenX or
PFO3TDA, below LC50 for these compounds (50, 100 and 10 ppm,
respectively), for 24 h, i.e., collected at 96 hpf. Additional exposure
replicates weremade to account for any losses due tomortality, and
in order to generate a sufficient number of embryos (N ¼ 100) and
replicates (n ¼ 3) to achieve quantitative NMR analyses. After
washing 3 times with MilliQ water to remove residual PFAS, em-
bryos were transferred to 4-mm zirconium oxide rotors (Bruker
BioSpin AG, Switzerland) to which 10 mL deuterated phosphate
buffer (100 mM, pH 7.0) containing 0.1% (w/v) 3-trimetylsilyl-
2,2,3,3-tetradeuteropropionic acid (TSP) was added as a reference
(1H chemical shift at 0 ppm).2.4. HRMAS NMR analysis
All HRMAS NMR experiments were performed on a vertical
Brukermagnet (DMX 600-MHz), which was equippedwith a 4-mm
HRMAS doubly tuned 1H/13C inverse probe with a magic angle
gradient. Measurements were carried out at a spinning rate of
6 kHz and a temperature of 277 K which was achieved by a Bruker
BVT3000 control unit. Data acquisition and processing were carried
out using Bruker TOPSPIN 2.1 software (Bruker Analytische Mes-
stechnik, Germany).
One-dimensional 1H HRMAS NMR spectra were obtained as
described previously (Roy et al., 2017). A zgpr pulse sequence (from
Bruker’s standard pulse program library) with water suppression
was used for one-dimensional 1H HR-MAS NMR spectra. Each one-
dimensional spectrum was acquired applying a spectral width of
8000 Hz, domain data points of 16k, number of averages of 512with
8 dummy scans, constant receiver gain of 2048, and acquisition
time of 2 s and relaxation delay of 2 s. The relaxation delay was set
to a small value to remove short T2 components due to the presence
of lipids in intact embryo samples. All spectra were processed by an
exponential window function corresponding to a line broadening
of 1 Hz and zero-filled before Fourier Transformation. NMR spectra
were phased manually, and automatically baseline corrected using
TOPSPIN 2.1 (Bruker Analytische Messtechnik, Germany). The total
analysis time (including sample preparation, optimization of NMR
parameters and data acquisition) of 1H-HRMAS NMR spectroscopy
for each sample was approximately 20 min.
All HRMAS NMR spectra were manually phased, baseline cor-
rected and analyzed using TOPSPIN 4.0.6 (Bruker Analytische
Messtechnik, Germany). Quantification of metabolites was per-
formed by Chenomx NMR Suite 8.2 (Chenomx Inc., Edmonton,
Alberta, Canada). The concentrations of metabolites were
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external reference may lead to misleading results, and tCr reso-
nance has been previously shown to be a reliable internal reference
in a wide range of animal studies. Statistical analysis of metabolite
quantification was done by one-way analysis of variance (ANOVA)
using OriginPro v. 8 (OriginLab, Northampton, MA, USA), and
calculated F-values larger than 2.8 (p < 0.05) were considered
significant. Multivariate analysis of the one-dimensional NMR
spectra were performed as described earlier (Roy et al., 2017; for
details, see Supplementary Materials).3. Results and discussion
3.1. Toxicity of PFECA and PFOA in the zebrafish embryo model
Toxicity of the PFECA and PFOA was evaluated for zebrafish
embryos continually exposed over 7 dpf at compound-specific
ranges of exposure concentrations. Concentration-dependent
toxicity of the PFECA was observed with respect to lethality
(Fig. S2) which was accompanied by clear impairment of develop-
ment and locomotory function. Generally speaking, median lethal
concentrations of PFECA (Table 1) were similar to those previouslyTable 1
Median lethal concentration (LC50) of PFECA and PFOA in the zebrafish
embryo model. Calculated values (in mM), along with 95% confidence
intervals, are specifically given for 24 h exposure of 3 h post-
fertilization (hpf) embryos. LC50 values were calculated by Probit anal-
ysis; dose-response curves are given in Supplementary Materials.
Shown, for comparison, are number of fluorocarbons (-CFx) and ether
oxygens (-O-) in the alkyl chain of each PFAS.
Alkyl Chain LC50 (mM) ± 95% CI
-CFx- -O-
PFECA
PFMOBA 5 1 499 ± 0.0
GenX 5 1 383 ± 30
PFDMMOBA 6 1 248 ± 81
PFO2HpA 4 2 441 ± 66
PFO2DA 7 2 157 ± 8
PFO3DA 6 3 202 ± 8
PFO3TDA 9 2 38 ± 6
PFOA 7 0 232 ± 29
Fig. 1. Increased mortality, as measured by median lethal concentrations (LC50), with continu
***) indicate that LC50 is significantly different (p < 0.001 and p < 0.0001) from 1 dpf valureported for other PFAS, i.e., 10e102 mM (Jantzen et al., 2016;Weiss-
Errico et al., 2017; Zheng et al., 2012), and LC50 values for PFOA
were, likewise, comparable to those previously reported (e.g., Ding
et al., 2013; Zheng et al., 2012) for this compound (i.e., 261 and
271 ppm, respectively). Although frequency of deformities was not
dose-dependent, a range of developmental deformity including
bent body axes and edema, as well as general moribundity
accompanied by sloughing of dermal layers, was observed in
approximately 7e10% of surviving embryos (Fig. S4). No significant
effect on hatching rate, however, was observed with >90% hatching
observed for both control and treated embryos by 4 dpf (data not
shown).
Embryo mortality, furthermore, increased for all PFECA and
PFOA over the 7 d continuous exposure (Fig. 1): median lethal
concentrations significantly decreased between 1 and 7 dpf for 6 of
the 7 PFECA including PFMOBA (p < 0.001), GenX (p < 0.0001),
PFO2HpA (p < 0.001), PFO2DA (p < 0.0001), PFO3DA (p < 0.001)
and PFO3TDA (p < 0.0001), as well as PFOA (p < 0.001), and
increased most drastically post-hatch (approximately 72 hpf).
(Fig. 1). Alongside cumulative toxicity (over total duration of
exposure), it is proposed that increased toxicity of PFAS at later
embryonic stages may be related to two factors. The first is a
development of the liver, and corresponding role hepatic enzyme.
Previous studies have demonstrated targeting of hepatocytes by
PFAS, and a role of the hepatic phase I (i.e., cytochrome P450 [CYP])
and phase II enzymes (e.g., glutathione-S-transferase [GST]) has
been specifically implicated in a range of mammalian and teleost
fish (e.g., carp, rare minnow) models (Cheng and Klaassen, 2008;
Liu et al., 2009, 2008; Rotondo et al., 2018). Targeting of hepatocytes
by PFECA and PFOA would be consistent with the significant in-
crease in toxicity at later stages of embryo development, as
observed in our study (Fig. 1), since it has been shown that differ-
entiation of the liver, and significant expression of relevant en-
zymes (e.g., CYP), in zebrafish occurs at approximately 72 hpf. A
similar increase in acute toxicity has, indeed, been previously
demonstrated for recognized hepatotoxins (e.g., aflatoxin, acet-
aminophen) in the zebrafish embryo model (Pandya et al., 2016;
Zuberi et al., 2019). Alternatively, stage-dependent toxicity of the
PFECA may be simply related to hatching e which, likewise, occurs
at approximately 72 hpf e and specifically, to a role of the chorion
as a barrier to these compounds. Recent studies have investigated
uptake and toxicokinetics of PFAS in the zebrafish embryo model,ous exposure of zebrafish embryos to PFECA and PFOA over 7 dpf. Asterisks (i.e., ** and
es. Error bars represent 95% confidence interval.
Fig. 2. Correlation between acute embryotoxicity, based on lethality (LC50) at 24 hpf, relative to alkyl chain length (A) and O/C ratio, as a measure of replacement of -CF2- by ether
oxygen, in alkyl chain (B) of PFECA and PFOA. Alkyl chain length is defined as number of carbon and oxygen atoms not including terminal carboxylic acid group. Significant
correlation was observed between alkyl chain length and LC50, whereas no significant correlation was observed between LC50 and ratio of O/C (i.e., number of ether groups) in the
alkyl chain. Pearson correlation coefficient (R), and statistical significance (p-value) are given for correlations.
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uptake until approximately 48 hpf after which uptake, as measured
by PFAS concentration in post-hatch embryos, steadily increased
(Huang et al., 2010; de Koning et al., 2015; Keiter et al., 2016; Vogs
et al., 2019).
Embryotoxicity (i.e., LC50) of PFECA was significantly correlated
with alkyl-ether chain length of PFECA (Fig. 2). A similar relation-
ship between alkyl chain length and both toxicity, and uptake and
bioconcentration, has been consistently reported for other PFAS in
numerous previous studies including the zebrafish model (Zheng
et al., 2012; Buhrke et al., 2013; Mahapatra et al., 2017; Vogs
et al., 2019; Wen et al., 2017). Uptake and subsequent toxicity are
presumptively due to the positive correlation between lipophilicity
and alkyl-ether chain length which is supported by a generally
positive correlation between lipophilicity and uptake previously
documented for a diversity of compounds in the zebrafish embryo
(Berghmans et al., 2008; de Koning et al., 2015; Jaja-Chimedza et al.,
2017). Most notably, the LC50 of PFOA generally falls within the
same range, relative to chain length, as PFECA (Fig. 2A), whereas the
degree of substitution of -CF2- by ether groups in PFECA (as
measured by O/C ratio of PFECA) was not correlated with toxicity
(Fig. 2B). Taken together, these findings suggest that while chain
length of PFAS (including both PFOA and PFECA) is consistently
correlated with embryo toxicity, the replacement of fluorocarbons
by ether, as in the PFECA, has no effect on toxicity in the zebrafish
embryo (as measured by lethality). This further suggests that acute
toxicity (and presumably toxicokinetics, i.e., uptake) are, in fact,
quantitatively similar for these next-generation chemical variants.
In addition to lethality, PFECAs and PFOA impaired embryo
development as evidenced by morphometric measurements, and
specifically IOD (Fig. 3A) as a proxy of embryo size (Weiss-Errico
et al., 2017). The effect, however, was independent (in the con-
centration range tested) of chain-length or any other apparent
structural feature. Generally speaking, all PFECA and PFOA signifi-
cantly (p < 0.0001) reduced IOD by nearly 50% (Fig. 3A). A similar
decoupling of lethality and morphometrically assessed develop-
mental toxicity was previously observed for PFOA in the zebrafish
embryo model (Weiss-Errico et al., 2017).
Finally, alongside lethality and developmental toxicity, several
of the PFECA signficantly affected locomotory behavior of exposed
zebrafish embryos, specifically measured by righting behavior e
and, to be exact, rate of listing - of hatched eleutheroembryos at 7
dpf (Fig. 3B). A similar effect was, in fact, previously reported for
PFOA in the zebrafish embryo model (Weiss-Errico et al., 2017).
Although 5 of the 7 PFECA, as well as PFOA, significantly increasedpercent of embryo listing (compared to controls) in the present
study, no quantitative relationship between chain length, or any
other structural feature of the compounds was discernible.
Whether the effect of PFECA and PFOA was due to neurotoxicity e
that is modulation of neurochemistry e or simply due to overall
developmental toxicity remains to be seen, however, alteration of
neural metabolites was, in subsequent metabolic profiling (dis-
cussed below), observed in the present study.3.2. HRMAS NMR metabolic profiling of PFAS-exposed zebrafish
embryos
Metabolic profiling of intact zebrafish embryos by HRMAS NMR
was undertaken to elucidate targets and pathways associated with
toxicity of three representative PFAS which were specifically
selected to include a previously well studied representative (i.e.,
PFOA), and PFECA (i.e., GenX and PFO3TDA) with variable levels of
embryo toxicity (i.e., low and high, respectively). More generally,
the three compounds represent three levels of toxicity, i.e.,
PFO3TDA > PFOA > GenX (Table 1 and Fig. S2).
Prior to exposures for metabolomics studies, embryo toxicity
was reassessed (see Supplementary Materials and Methods) to
confirm relative toxicity, and establish appropriate concentrations
and developmental stage for exposures. These assessments estab-
lished sub-lethal concentrations (Fig. S3) for which embryos were
generally indistinguishable from untreated controls, and severely
moribund embryos as seen at higher exposure concentrations
(Fig. S4), were not observed. Exposure concentrations employed
(50, 100 and 10 ppm for PFOA, GenX and PFO3TDA, respectively)
were 2e3 orders of magnitude higher than levels typically
measured in drinking water, and those measured in human serum,
which are typically ppb levels or less (although serum levels as high
as 1 ppm have, in fact, been measured in occupationally exposed
individuals; Worley et al., 2017; Sunderland et al., 2019). These
relatively high (yet sub-lethal) levels were selected, however, to
assure a sufficient and significant alteration in metabolomics
studies. An exposure window from 72 to 96 hpf was, furthermore,
established. At this stage, most relevant organ systems (e.g., liver,
kidney) are largely differentiated, and key aspects of CNS devel-
opment occur, or have occurred, including formation of the
midbrain-hindbrain boundary (~27 hpf), and elaboration of telen-
cephalon, mesencephalon, hypothalamus and, importantly, pri-
mary and secondary motor neurons (~96 hpf). No apparent
developmental effects with respect to these systems were observed
during the exposure period (between 72 and 96 hpf) for any of the
Fig. 3. Developmental impairment and behavioral dysfunction of zebrafish embryos (at 7 dpf) exposed to PFECA and PFOA. (A) Interocular distance (IOD), as a morphometric
measure of embryo body size, for surviving embryos exposed to sublethal concentrations (<LC50) of PFECA and PFOA at 7 dpf, compared to controls. The IOD was significantly
reduced (***p < 0.0001) for embryos exposed to all PFECA and PFOA, compared to controls. (B) Percent listing of surviving embryos exposed to sublethal concentrations (<LC50) of
PFECA and PFOA at 7 dpf, compared to controls. Percent listing was significantly higher for embryos exposed to PFDMMOBA, PFO2DA, PFO3DA, PFO3TDA and PFOA
(*** ¼ p < 0.0001), as well as PFMOBA (**p < 0.005). Error bars represent 95% CI.
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Highly-resolved and reproducible NMR spectra were obtained
from intact control and PFAS-treated embryos (Fig. S5), and quan-
titative analysis revealed significant alteration of 33 metabolites by
one or more of the PFAS evaluated (Fig. 4 and Table S1). Principal
components analysis, furthermore, showed that metabolic profiles
of the three PFAS, and untreated control, could be clearly discerned
suggesting a significant quantitative difference in the metabolic
profiles affected (Fig. S6). Notably, the percent of metabolites
altered was positively correlated with LC50 of the PFAS (Fig. 5),
suggesting that metabolic effects paralleled acute toxicity. Quali-
tatively, however, there was considerable overlap in terms of the
metabolites affected by exposure. Generally speaking, metabolite
levels altered by PFAS could be grouped into several categories
including (1) indicators of hepatotoxicity; (2) modulation of neural
metabolites and/or pathways; (3) metabolites associated with
oxidative stress; and moreover, (4) interrelated carbohydrate, lipid
and amino acid metabolism, and associated cellular energetics.
3.3. An integrated system-level model of metabolic targets and
pathways of PFAS toxicity
Taken together, the metabolic alterations observed in the pre-
sent study enabled an integrated model of the metabolic pathways
of PFAS toxicity in the zebrafish embryo (Fig. 6). Although the
current study is the first to utilize metabolomics of the zebrafish
embryo to investigate PFAS - and the first omics study of any PFECA- previous ex vivo transcriptomics (Peng et al., 2013), proteomics
(Shao et al., 2018) and metabolomics (Peng et al., 2013; Shao et al.,
2018; Yu et al., 2016) studies have been conducted for PFOA in other
cellular and/or organismal systems. As such, metabolic profiles
observed in the present study are perhaps best interpreted relative
to this legacy PFAS. That said, metabolites altered by exposure to
both PFO3TDA and GenX were quite similar to PFOA (Fig. 4 and
Table S1), and the differences between the three representative
PFAS could be largely explained based on relative toxicity (Fig. 5).
Accordingly, this model could generally, therefore, be extended to
the PFECA.
At the organ system (and corresponding cellular) level, several
previous studies have suggested that PFAS target liver (i.e., hepa-
tocyte) and kidney due, most likely, to the general role of these
organ systems in detoxification and depuration of xenobiotics
(Mortensen et al., 2011). Cellular uptake, and consequent tissue
distribution, of PFOA has been shown in numerous studies to be
specifically facilitated by solute carrier (SLC) transporters that are
primarily localized to liver and kidney (Yang et al., 2010; Popovic
et al., 2014; Zhao et al., 2016; Kimura et al., 2017). Consistent
with targeting of hepatocytes, an observed stage-dependence of
PFOA toxicity in the present study coincides (as discussed above)
with differentiation (at ~ 72 hpf) of the liver as a target organ.
Specifically alignedwith hepatotoxicity, PFOA (p < 0.005), PFO3TDA
(p < 0.000001) and GenX (p < 0.05) all showed a significant re-
ductions in the molar ratio of branched-chain to aromatic amino
acids (BCAA/AAA) relative to negative controls (Table S1). Altered
Fig. 4. Effect of PFOA, PFO3TDA and GenX treatment on the metabolic profile of intact zebrafish embryos. Zebrafish embryos (3 dpf) were exposed to 50 ppm PFOA, 10 ppm
PFO3TDA or 100 ppm GenX for 24 h. Shown are concentrations of metabolites relative to total creatine (tCr); values are average ± SE of mean. #P < 0.01, *P < 0.05. Abbreviations:
Phe ¼ phenylalanine; Trp ¼ tryptophan; Tyr ¼ tyrosine; Leu ¼ leucine, Ile ¼ isoleucine; Val ¼ valine; Glu ¼ glutamate; Gln ¼ glutamine; Gly ¼ glycine; Ala ¼ alanine;
Asp ¼ aspartate; Cys ¼ cysteine; GABA ¼ g-aminobutyric acid; GSH ¼ glutathione; Glc ¼ glucose; G1P ¼ glucose-1-phosphate; G6P ¼ glucose-6-phosphate; Lac ¼ lactate;
ATP ¼ adenosine triphosphate; ADP ¼ adenosine diphosphate; NADH/NADþ ¼ reduced/oxidized nicotinamide adenine dinucleotide; m-Ins ¼ myo-inositol; Cho ¼ choline;
GPC ¼ glycerophosphocholine; Chol ¼ cholesterol; FA ¼ fatty acids.
Fig. 5. Change in metabolite levels relative to acute toxicity. Acute toxicity is repre-
sented by LC50 values for PFAS. Hepatotoxicity (using BCAA/AAA ratio as biomarker)
correlated with LC50 (A). Similarly, percentage of metabolites altered versus LC50 was
correlated, suggesting a quantifiable coupling between acute toxicity and level of
metabolic effects (B). Asterisks indicate significant difference between treatments and
control with respect to BCAA/AAA ratio: *p < 0.05, **p < 0.005, ***p < 0.000005.
Letters associated with error bars indicate significant difference (p < 0.05) between
treatments with respect to BCAA/AAA ratio (y-error bars) and LC50 (x-error bars).
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indicator of liver damage (Muratsubaki and Yamaki, 2011), and in
similar studies, has been recently found to parallel hepatotoxicity in
the intact zebrafish embryo model (Zuberi et al., 2019). Further-
more, BCAA/AAA ratio was significantly correlated with LC50,
underscoring hepatocytes as a target of acute toxicity (Fig. 5,
Table S1).
Presumably reflective of the relatively higher hepatotoxicity, a
significant decrease in trimethylamine N-oxide (TMAO) was
uniquely observed for PFO3TDA (as the most toxic PFAS tested).
TMAO is the product of the oxidation of trimethylamine, exclusively
by hepatic flavin-containing monooxygenase 3 (FMO3), which is, in
turn, derived frommetabolism of choline and betaine (among other
diet-derived precursors) by enteric microbiota (Alfieri et al., 2008;
Janeiro et al., 2018; Lang et al., 1998). Choline and betaine, in fact,
are typically correlated - as companion biomarkers - with TMAO
levels (Janeiro et al., 2018), and were both increased in the present
study (for all PFAS treatments). Higher acute hepatotoxicity of
PFO3TDA, therefore, is likely to result in a decrease of FMO3 func-
tion, and the consequent reduction in TMAO levels observed here.
Moreover, TMAO (along with its metabolic precursors, i.e., betaine
and choline) has been proposed as a biomarker for metabolic syn-
drome (Barrea et al., 2019; Janeiro et al., 2018), and as such, is
perhaps not only reflective of hepatoxicity, but thus, also aligns
with the reported link between PFAS and metabolic syndrome
(Matilla-Santander et al., 2017; Christensen et al., 2019), and
numerous metabolic alterations observed in the present study
Fig. 6. A model of the targeting of mitochondria and PPAR by PFOA in relation to changes in metabolic alterations. Abbreviations: TCA ¼ Tricarboxylic acid cycle, i.e., citric acid cycle;
PPAR ¼ peroxisome proliferator-activated receptor; BCAA ¼ branch-chained amino acids; BCATm ¼ branch-chained amino acid aminotransferase; BCKA ¼ branch-chained keto
acid; BCKDH ¼ branch-chained alpha-keto acid dehydrogenase; AcCoA ¼ acetyl CoA; CPT1 and CPT2 ¼ carnitine palmitoyl transferase I and II; FAC ¼ fatty acyl carnitine;
OxPhos ¼ oxidative phosphorylation; ROS ¼ reactive oxygen species; PL ¼ phospholipids; PC ¼ phosphatidylcholine; SLC ¼ solute carrier transport protein; a-KG ¼ alpha-
ketoglutarate; GLUT ¼ glucose transporter; for other metabolite abbreviations, see Fig. 4.
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mia (as discussed below).
A significant decrease in GSH (Fig. 4) may, furthermore, corre-
late with targeting of hepatocytes by PFOA. Although GSH is a
ubiquitous antioxidant in biological systems, it is particularly
associated with Phase II detoxification which is localized to the
liver, and numerous studies have similarly reported decreases in
GSH in association with hepatotoxicity (Maddox et al., 2009; Song
et al., 2003). That said, a decrease in GSH may be more generally
linked to the well-established induction of oxidative stress by PFAS
mediated by mitochondrial impairment (Hagenaars et al., 2013; Liu
et al., 2007; Tang et al., 2018).
Although liver and kidney have been most frequently linked to
PFOA toxicity, there is a considerable body of evidence to suggest
that neuronal dysfunction may contribute to deleterious effects
(Johansson et al., 2008). Behavioral impairment (Fig. 3B) observed
in the current study is consistent with effects on neural systems,
and several metabolites affected by PFAS are, likewise, aligned with
possible neurotoxicity and/or neurodevelopmental toxicity (Fig. 4).
Among these, levels of the metabolically interrelated neurotrans-
mitters, Glu and GABA, were significantly reduced with exposure to
PFAS. At the same time, the concentration of NAAwhich is uniquely
associated with (and one of the most abundant metabolites, second
only to Glu, in) neural cells was significantly decreased. Bio-
synthesized from Asp and acetyl CoA in the mitochondria of neural
cells, the observed decrease in NAA would be consistent with not
only general targeting of neural cells, but specifically mitochondria(discussed below; Fig. 5). Alterations of NAA have, furthermore,
been recently proposed as a biomarker of disruption of the inter-
action between neurons and glial cells including myelination, i.e.,
oligodendrocyte/neuron interactions (Xu et al., 2016). Interestingly,
the ratio of Gln/Glu (whichwas increased in PFAS-treated embryos)
has been, likewise, suggested to be a metabolic indicator of
impaired astrocyte-neuron interaction, based on the role of the
“glutamate/glutamine cycle” in the shuttling and recycling of Glu/
GABA between astrocytes and neurons (Pereira et al., 2008; Xu
et al., 2016), and may be further suggestive of the disruption of
the astrocyte-neuron interaction by PFAS.
At the subcellular and molecular level, two interrelated targets
of PFAS (including PFOA) have been most frequently identified:
namely, (1) disruption of mitochondria, and (2) pathways associ-
ated with activation of peroxisome proliferator-activated receptors
(PPAR). Multiple studies in cell-based systems have shown that
PFOA causes mitochondrial dysfunction including swelling and
disruption of membrane integrity, membrane potential collapse
with disruption of the electron transport chain, and consequent
reduction in ATP levels (Choi et al., 2017; Mashayekhi et al., 2015;
Suh et al., 2017) At the same time, mitochondrial dysfunction has
been linked to the induction of oxidative stress by PFOA (including
studies in the zebrafish model; Hagenaars et al., 2013). Molecular
studies, on the other hand, have consistently documented the
activation of PPAR - and in particular, the PPARa and PPARg sub-
types - by PFOA (Abbott et al., 2012; Buhrke et al., 2013; Kennedy
et al., 2004; Takacs and Abbott, 2006; Vanden Heuvel et al.,
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metabolism including b-oxidation, lipid biosynthesis and transport,
ketogenesis, adipogenesis, and glucose homeostasis (i.e., glucose
biosynthesis, catabolism, storage and transport) (Dubois et al.,
2017; Peeters and Baes, 2010; Tan et al., 2005). Co-targeting of
mitochondria and PPAR by PFOA is highly interrelated as both have
key functions in cellular energetics as it relates, in particular, to
carbohydrate (i.e., glucose) and lipid metabolism, and conse-
quently, metabolic syndrome (Alderete et al., 2019; Cardenas et al.,
2018; Christensen et al., 2019; Lin et al., 2009). Indeed, the alter-
ation of numerous metabolites observed in the present study,
likewise, points to the co-targeting of mitochondria and PPAR-
regulated pathways as reflected by both apparent oxidative stress
responses and impairment of cellular energetics including path-
ways relevant to metabolic syndrome, e.g., carbohydrate and
glucose metabolism (Fig. 5). Alterations in metabolic profiles in
relation to these two targets e as part of an integrated model - are
discussed separately below.3.3.1. Apparent disruption of mitochondrial pathways by PFAS
Several of the changes in metabolite profiles of PFAS-exposed
zebrafish observed in the present study align with mitochondrial
dysfunction in association with toxicity. Consistent with a
compromise of mitochondrial membrane integrity, as previously
established for PFOA (Hagenaars et al., 2013), significant increases
in choline and glycerophosphocholine (GPC) were observed, and
are possibly indicative of release and hydrolysis of phospholipids -
following presumptive disruption of mitochondrial membranes e
including, in particular, phosphatidylcholine as one of the most
abundant (and typically most abundant) classes of lipids in mito-
chondrial membranes (Almaida-Pagan et al., 2014; de Kroon et al.,
1997). Increased concentration of polar head-groups of membrane
phospholipids (e.g., choline, GPC, ethanolamine, myo-inositol) as,
likewise, measured by HRMAS NMR of intact zebrafish embryos
has, in fact, been similarly linked in previous studies to membrane
disruption in this system (Berry et al., 2016; Roy et al., 2017; Zuberi
et al., 2019).
Most conspicuously, alteration of several metabolites associated
with the tricarboxylic acid (TCA, or “citric acid”) cycle, and associ-
ated electron transport chain and oxidative phosphorylation, is
directly aligned with disruption of mitochondria. Key changes
associated with PFAS exposure, in this regard, include significant
decreases in citrate and succinate, and increase of malate, as well as
apparent metabolic accumulation of acetate, which generally
indicate disruption of the TCA cycle, and an inability of carbon (via
acetyl CoA) to enter the cycle (Fig. 5). Reductions in citrate and
succinate, and increase in malate, which are associated with irre-
versible steps specifically point to inhibition of the aldol conden-
sation of acetyl CoA and OAA as entry point (which, in turn, links
glycolysis and b-oxidation) to the TCA cycle. Exclusively for
PFO3TDA, fumarate was additionally increased, and likely reflects
consequent upstream metabolic accumulation (from malate to
fumarate) owing to the higher toxicity (and associated mitochon-
drial disruption) of this compound. Alongside changes in TCA cycle
metabolites, significant decreases in the energetic currencies of
NADH and ATP would correlate with inhibited yield of the former,
and consequent lack of availability of this reducing agent for
oxidative phosphorylation to produce the latter (Fig. 5).
Upstream of the TCA cycle, the observed alteration of metabo-
lites associated with glycolysis and b-oxidation (which supply ac-
etate to the TCA cycle) similarly indicate mitochondrial dysfunction
and/or impairment of the transport of metabolic intermediates
(from cytosol to the mitochondria) as part of these pathways
(Fig. 5). Aerobic glycolysis in the cytosol, for example, providespyruvate that is, in turn, transported to mitochondria where con-
version by pyruvate dehydrogenase (PDH) within the mitochon-
drial matrix provides acetyl CoA for entry to the TCA cycle. The
observed increase in pyruvate, therefore, may extend the metabolic
accumulation (from acetate) associated with loss of TCA cycle
function, and PDH activity. With respect to b-oxidation, one
particularly telling response for the two most toxic PFAS (i.e., PFOA
and PFO3TDA) may be a significant decrease in carnitine. Carnitine
is essential to the transport of fatty acids (via coenzyme A-acti-
vated, i.e., acyl CoA, intermediates) whereby carnitine palmitoyl-
transferases (CPT) located in the outer and inner mitochondrial
membranes (i. e., CPT I and II, respectively), catalyze formation of
acyl carnitines for transport into the mitochondrial matrix (where
b-oxidation of FA occurs), and subsequent recycling of carnitine
(back to the cytosol). Decreased carnitine, therefore, likely reflects a
decrease in the mitochondrial capacity for b-oxidation, and
consequently diminished recycling of free carnitine, for these two
most toxic PFAS (Fig. 5).
Alongside alterations of TCA cycle intermediates and precursors,
auxiliary pathways are also seemingly affected by PFAS presumably
due to impairedmitochondrial function. For example, in addition to
their role in neurotransmitter recycling, Glu and Gln are important
metabolic intermediates for entry to the TCA: cytosolic Gln is
transported to the mitochondria, and converted within the mito-
chondrial matrix to Glu (by glutaminase) which can, in turn, enter
the TCA cycle via a-ketoglutarate (aKG). Accordingly, the observed
increase in Gln/Glu ratio is consistent with disruption of mito-
chondria. At the same time, Pro derived from collagen in the
extracellular matrix during times of metabolic stress can be
catabolized to Glu (to supply anaplerotic aKG to the TCA cycle) by
proline oxidase (POX) which is localized to the inner membrane of
the mitochondria (Phang et al., 2008). Thus, the significant increase
in Pro, likewise, aligns with mitochondrial dysfunction, and spe-
cifically loss of POX activity (Fig. 5).
Finally, with respect to the role of mitochondria, previous
studies have generally linked PFAS to increased production of
reactive oxygen species (ROS) and consequent oxidative stress due
to mitochondrial dysfunction (Liu et al., 2007; Suh et al., 2017;
Wielsøe et al., 2015). Additionally, PFOA has been shown to
decrease levels of nuclear factor erythroid 2-related factor (Nrf2)
which is a key transcription factor required for induction of
numerous genes involved in antioxidant response including GSH
biosynthesis (Liu et al., 2015). The observed decrease in GSH for
PFAS exposures would, therefore, generally align with both oxida-
tive stress (i.e., production of ROS) and consequent depletion of the
peptide, as well as reduced biosynthesis (via Nrf2). A similar
decrease in GSH has, in fact, been consistently observed in associ-
ation with PFOA-induced oxidative stress (Liu et al., 2007). In par-
allel, a marked increase in taurine was, furthermore, observed for
all PFAS in the present study. Taurine has an established role in
antioxidant defenses (Schaffer et al., 2009), and likewise, may
indicate an upregulation in response to oxidative stress in zebrafish
embryos. Moreover, taurine is associated with Nrf2 translocation
(Sun et al., 2018), and therefore, may be directly involved in the
upregulation of antioxidant responses.
3.3.2. Role of PPAR-regulated pathways in metabolic disruption by
PFAS
Alongside mitochondria, PPAR has been consistently demon-
strated to be a key target in PFAS toxicity. As transcription factors,
PPAR are involved in the expression e specifically via PPAR
response elements (PPRE) - of a wide range of genes, and accord-
ingly, diverse cellular and biochemical pathways. However, the best
described functions involve regulation of energy homeostasis
including carbohydrate and lipid metabolism, and targeting of
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increased rates of obesity, diabetes and other related metabolic
disorders (Liu et al., 2018). Although PPAR expression was not
directly measured in the present study, numerous alterations of
metabolic profiles by PFAS (described below) are consistent with a
role of PPAR-regulated pathways.
Fatty acids are recognized as endogenous ligands for PPAR, and
thereby, represent a direct link between PPAR and lipid meta-
bolism, specifically via b-oxidation. As a proposed mechanism of
action, PFOA have been shown to bind and activate PPAR (Vanden
Heuvel et al., 2006; Yamamoto et al., 2014), and induce b-oxida-
tion of fatty acids (Kudo et al., 2006; Yu et al., 2016). An expected
decrease in fatty acids (via induction of b-oxidation), however, was
only observed for PFO3TDA (Fig. 4) as the most toxic of the PFAS
investigated. That said, any PPAR-directed induction of b-oxidation
would likely be confounded by concomitant disruption of mito-
chondria (where b-oxidation occurs) by PFAS. Presumptive mito-
chondrial disruption may, thus, explain a lack of significant
alteration in fatty acids (except for the most toxic PFO3TDA) due to
impaired carnitine-based fatty acid transport pathways (as sug-
gested by elevated carnitine levels observed here). Alongside a
direct role in the catabolism (i.e., b-oxidation) of fatty acids, how-
ever, PPAR have also been shown to regulate lipid metabolism via
other direct and indirect routes. Most notably, PPAR have been
shown to regulate multiple pathways associated with metabolism
and transport of cholesterol (Li and Chiang, 2009). Significant
decrease in cholesterol with PFOA and PFO3TDA treatment
observed in the present study (Fig. 4) may, therefore, be explained
by the effect of these PFAS on PPAR-mediated pathways of
cholesterol metabolism and uptake.
Although PPAR has been perhaps most widely investigated with
respect to lipid metabolism, considerable evidence supports
diverse roles in the regulation of glucose metabolism including
glycolysis, gluconeogenesis and glycogen metabolism (Peeters and
Baes, 2010). And concomitantly, multiple studies have suggested a
role of altered glucose metabolism in the adverse effects of PFOA
(Yan et al., 2015; Zheng et al., 2017). Activation of PPARg by the
agonist fenofibrate, for example, was previously shown (Oosterveer
et al., 2009) to reduce glycolytic flux of glucose (via G6P) through
glucokinase (i.e., hexokinase IV), as a key step in glycolysis, with
diversion toward gluconeogenesis. At the same time, studies (Im
et al., 2011) identified a PPRE within glucose-6-phosphatase
(G6Pase), and demonstrated that PPARa upregulates this enzymes
as the key final step in liver gluconeogenesis. Accordingly, PFAS
activation of PPAR would be, likewise, expected to reduce G6P and
increase glucose due to reduced glycolytic flux and/or upregulation
of gluconeogenesis. Increased glucose was, indeed, observed for all
PFAS evaluated in the present study (Fig. 4). A significant elevation
in glucose was accompanied, in the case of PFO3TDA, by a decrease
in lactate which may further reflect a decrease in glycolytic flux e
and specifically anaerobic glycolysis (with lactate as end product)e
or alternatively, increased hepatic gluconeogenesis from lactate
(e.g., Cori cycle). That said, although a concomitant decrease in G6P
(along with increased glucose) was observed for PFOA, this was not
the case for either PFECA (Fig. 4).
In contrast to PFOA, PFO3TDA was actually found to increase
G6P (rather than decrease as observed for PFOA), and taken
together with a decrease in glucose-1-phosphate (G1P) that was,
likewise, exclusively observed for PFO3TDA exposures, points to a
possible role of glycogen metabolism in the case of this more toxic
PFAS. Indeed, alongside glucose anabolism (i.e., gluconeogenesis)
and catabolism (i.e., glycolysis), PFAS have been shown in multiple
studies to alter glycogen metabolism. Specifically, PFOA was found
to decrease liver glycogen with a concurrent increase in G6Pase as
the final step in glycogenolysis, and decrease in glycogen synthase(GS) as the key regulatory step of glycogenesis (Zheng et al., 2017).
Both of these enzymes, in turn, have been shown to be regulated by
PPAR (Im et al., 2011; Mandard et al., 2007). More recently, PFOA
was found to significantly decrease in glycogen (Hagenaars et al.,
2013). Although a precise mechanistic role of PPAR in regulating
glycogen metabolism remains unclear (Bandsma et al., 2004;
Mandard et al., 2007; Oosterveer et al., 2009; Peeters and Baes,
2010), G1P is more or less exclusively associated with glycogenol-
ysis (and, in reverse, glycogenesis), such that the concurrent in-
crease in G1P, G6P and glucose for PFO3TDA-exposed embryos is
highly consistent with a role of increased glycogenolysis (in relation
to the higher toxicity of this variant). The increase of G6P (from
glycogenolysis) could, in turn, offset any expected decreases of this
metabolite resulting from reduced glycolytic flux and/or increased
gluconeogenesis (as discussed above). Of additional note, the in-
crease in G6P (exclusively for PFO3TDA-exposed embryos) is
mirrored by a similarly unique increase in myo-inositol (Fig. 4) for
which G6P is the rate-limiting biosynthetic substrate.
Although exposure to GenX did significantly increase glucose,
none of the intermediates associated with glucose or glycogen
metabolism, on the other hand, were significantly altered. It is
proposed that elevated glucose, in this case, may be related instead
to intercellular glucose transport, and the established role of PPAR
in the expression of glucose transporters. Numerous studies,
indeed, have shown that PPAR activation upregulates expression
and/or translocation of bidirectional glucose transport (GLUT)
proteins including, in particular, GLUT2 in the liver as the primary
transporter of glucose between liver and blood (Dasgupta and Rai,
2018; Im et al., 2005; Kim and Ahn, 2004; Liao et al., 2007; Variya
et al., 2019; Wu et al., 1998). Consistent with effects on glucose
transport, PFOA exposure was previously found (in a mouse liver
model) to decrease glucose in liver, while simultaneously
increasing blood glucose, by directing hepatic glucose away from
glycogen synthesis, and into the bloodstream toward other systems
including various non-glycogen synthesizing cells, thus effectively
increasing total “free” glucose (Zheng et al., 2017). Though only
total glucose, and not cell-specific levels, in zebrafish embryos were
measured in the present study, increased GLUT2 may, therefore,
alternatively (in the case of GenX) or additionally explain observed
elevation of glucose as a result of “escape” from hepatic glycogen-
esis (Fig. 6).
On this note, one of the most revealing differences in metabolic
profiles between PFOA and PFECA is the relative changes in BCAA
which are, in fact, well documented regulators of GLUT (Holecek,
2018; Zhang et al., 2017) and in turn, known to be regulated by
PPAR. As essential amino acids, levels of BCAA are exclusively
regulated by catabolism which takes place by a two-step process
involving (1) the reversible conversion of BCAA to corresponding a-
keto acids by BCAA amino transferases (BCAT) in extrahepatic cells,
and (2) the subsequent rate-limiting irreversible decarboxylation
by branched-chain keto acid dehydrogenase (BCKDH), primarily in
hepatocytes, following transport of a-keto acids to the liver (Li et al.,
2017). Both enzymes have been shown to be upregulated by acti-
vation of PPARg, and downregulated when PPARg genes are
knocked-out (Blanchard et al., 2018). Enzymes involved in both
steps, however, are either exclusively (i.e., BCKDH) or primarily
localized to mitochondria (García-Espinosa et al., 2007; Holecek,
2018). In the case of PFOA, all BCAA were significantly increased,
and it is proposed that mitochondrial disruption, therefore, may
supersede PPAR-mediated effects (i.e., increased BCAA catabolism)
whereby impairment of mitochondrial BCKDH would reduce
catabolism, and consequently lead to the observed accumulation, of
BCAA (which could, in turn, upregulate GLUT, and contribute to the
observed increase in glucose).
In contrast to PFOA, however, BCAAwere either not significantly
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valine), by both PFO3TDA and GenX (Fig. 4). In light of presumptive
mitochondrial disruption (and consequent loss of BCAT and BCKDH
catabolic activity which would be expected to increase BCAA
levels), the lack of altered BCAA levels by PFECA may imply other-
wise increased BCAA catabolism. In this regard, although BCAT is
mostly localized to the mitochondria, cytosolic BCAT is abundant in
certain cell types including, in particular, the CNS (García-Espinosa
et al., 2007), where the first step of catabolism could, thus, conse-
quently occur despite mitochondrial disruption (and loss of BCKDH
activity). Further aligned with a possible increase in BCAA catabo-
lism, alanine levels were also uniquely increased for both PFECA
(but not PFOA); during transamination by BCAT, the amino group
from glutamate (following deamination of BCAA) is transferred to
alanine, and thus, increased BCAA catabolism would, indeed, be
expected to increase alanine. At the same time, the observed in-
crease in NADþ for PFECA-exposed embryos (and not PFOA) may
reflect an upregulated BCAA catabolism by BCAT (in the absence of
mitochondrial BCKDH). Specifically, it has been shown (Islam et al.,
2010; Hutson et al., 2011) that in the absence of BCKDH activity,
NADþ (which would, otherwise, be recycled to NADH in the pres-
ence of BCKDH) accumulates. Differences in the alteration of BCAA
levels (and associated metabolites, i.e., alanine, NADþ) between
PFECA and PFOA may, therefore, point to differences in their effects
on catabolic pathways including cell-specificity, or differential de-
grees of interaction (i.e., activation) with PPAR (increasing BCAA
catabolism), compared to mitochondrial disruption (decreasing
BCAA catabolism), or alternatively, toward particular subtypes, i.e.,
PPARa versus PPARg. These hypotheses, however, remain to be
investigated.
Finally, it is noteworthy that cysteine levels are uniquely
decreased in embryos exposed to PFECA. Pathways targeted by
PFECA with respect to the observed alteration of cysteine are not
immediately clear. Cysteine has been linked to obesity, however,
and depletion of cysteine was found to prevent induction of PPARg
and adipose differentiation (Haj-Yasein et al., 2017). At the same
time, evidence suggests a role of PPARg in the regulation of genes
involved in biosynthesis including cystathionine g-lyase (Yang
et al., 2018) and cystathionine b-synthase (Mishra et al., 2010). It
is possible that differential effects in relation to cysteine may,
likewise, be linked to differences between PFOA and PFECA in terms
of interactions with PPAR (and/or subtypes). However, these pos-
sibilities similarly remain to be investigated.4. Conclusions
In conclusion, our findings confirm that PFECA are quantita-
tively and qualitatively (with respect to metabolic alterations)
similar in toxicity to PFOA, as a “legacy” PFAS, in the zebrafish
embryo system. Metabolic alterations are, furthermore, consistent
with a previously reported link between PFAS and hepatotoxicity,
neurotoxicity and metabolic syndrome including roles of mito-
chondria and PPAR, and may represent a model system for inves-
tigating this linkage. These findings most generally suggest that
these next-generation PFAS need to be equally considered as
environmental toxicants of potential concern.
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